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Although T-cell immunoglobulin mucin 3 (TIM-3) does
not contain inhibitory or death signaling motifs in its cyto-
plasmic domain, it has been proposed to be associated
with T cell suppression and/or exhaustion. However,
several lines of evidence suggest that TIM-3 can stimulate
T cells as a costimulatory molecule by coupling Src family
tyrosine kinase Fyn and the p85 phosphatidylinositol
3-kinase (PI3K) adaptor to TCR signaling. We examined
the expression pattern and function of TIM-3 and other
immune checkpoint receptors, CTLA-4 and PD-1 on
tumor infiltrating lymphocytes (TIL), compared to those
of peripheral blood T lymphocytes (PBL) in patients with
head and neck cancer (HNC). Here, we report that TIM-3
+CD8+ TIL express higher granzyme B/perforin, more
actively proliferate under anti-CD3/-CD28 stimulatory
conditions, and are more resistant to activation induced
cell death than TIM-3-CD8+ TIL, indicating TIM-3 can
positively regulate T cell responses. Analysis of down-
stream signaling molecules including phosphorylated JAK/
STAT-1, PD-1/SHP-2, and costimulatory CD137 in CD8+
TIL subsets supports our observation that TIM-3+CD8+
TIL are activated cells in HNC patients. However, PD-1
and CTLA-4 can negatively regulate immune responses of
TIM-3+CD8+ and TIM-3+CD4+ TIL respectively. More
importantly, neoadjuvant immunotherapy of HNC
patients with the EGFR-specific mAb cetuximab increased
both TIM-3 and PD-1 expression on CD8+ TIL, which
was correlated with higher granzyme B/perforin expres-
sion in TIM-3+CD8+ TIL. Taken together, these findings
suggest that TIM-3 functions as a positive regulator of
activated T cells in the tumor microenvironment while
CTLA-4 and PD-1 modulate the function of activated
TIM-3+ TIL. We therefore suggest that TIM-3 can be
used as a biomarker to indicate activation status of T cells
in the tumor microenvironment depending on PD-1
co-expression, particularly in response to cancer therapy
including cetuximab-based immunotherapy.
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